publication venue for
- Brain aging patterns in a large and diverse cohort of 49,482 individuals. 2024
- Author Correction: Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.. 30:-. 2024
- Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risks.. 30:1711-1721. 2024
- Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.. 30:1085-1095. 2024
- Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.. 29:2481-2488. 2023
- Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial.. 29:2358-2365. 2023
- CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease.. 29:1954-1963. 2023
- CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.. 29:1710-1717. 2023
- Clonal hematopoiesis is associated with protection from Alzheimer's disease.. 29:1662-1670. 2023
- Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial.. 29:880-887. 2023
- Implementing clinical trial data sharing requires training a new generation of biomedical researchers.. 29:298-301. 2023
- Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit.. 29:2526-2534. 2023
- CSF tau microtubule-binding region identifies pathological changes in primary tauopathies.. 28:2547-2554. 2022
- Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline.. 28:2381-2387. 2022
- Cellular senescence and senolytics: the path to the clinic.. 28:1556-1568. 2022
- An ethical plan for including forcibly displaced persons in omics and digital technology research.. 28:1116-1120. 2022
- A multisystem, cardio-renal investigation of post-COVID-19 illness.. 28:1303-1313. 2022
- The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.. 27:1954-1960. 2021
- Why aducanumab is important.. 27:-. 2021
- A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.. 27:1187-1196. 2021
- Direct-to-consumer personal genomic tests need better regulation.. 27:940-943. 2021
- SARS-CoV-2 infection of the oral cavity and saliva.. 27:892-903. 2021
- Post-acute COVID-19 syndrome.. 27:601-615. 2021
- Recommendations for measuring HIV reservoir size in cure-directed clinical trials.. 26:1339-1350. 2020
- Author Correction: Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer's disease.. 26:-. 2020
- Large-scale proteomic analysis of Alzheimer's disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation.. 26:769-780. 2020
- A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease.. 26:398-407. 2020
- Chronic inflammation in the etiology of disease across the life span.. 25:1822-1832. 2019
- Undulating changes in human plasma proteome profiles across the lifespan.. 25:1843-1850. 2019
- Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.. 25:1680-1683. 2019
- Neurogenetic contributions to amyloid beta and tau spreading in the human cortex.. 24:1910-1918. 2018
- Senolytics improve physical function and increase lifespan in old age.. 24:1246-1256. 2018
- Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.. 24:931-938. 2018
- Selective modulation of the androgen receptor AF2 domain rescues degeneration in spinal bulbar muscular atrophy.. 24:427-437. 2018
- IRF3 and type I interferons fuel a fatal response to myocardial infarction.. 23:1481-1487. 2017
- Gpr124 is essential for blood-brain barrier integrity in central nervous system disease.. 23:450-460. 2017
- Caspase-2 and tau-a toxic partnership?. 22:1207-1208. 2016
- A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance.. 22:421-6. 2016
- PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically.. 22:37-45. 2015
- Translational strategies and challenges in regenerative medicine.. 20:814-21. 2014
- Ironing out tau's role in parkinsonism.. 18:197-8. 2012
- Finding a sirtuin truth in Huntington's disease.. 18:24-6. 2012
- Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death.. 17:692-9. 2011
- Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets.. 18:153-8. 2011
- Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease.. 16:998-1000. 2010
- Memantine strikes the perfect balance.. 15:1355-6. 2009
- Getting a handle on Huntington's disease: silencing neurodegeneration.. 15:252-3. 2009
- NF-kappaB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF.. 13:62-9. 2006
- Taming the clot-buster tPA.. 12:993-4. 2006
- Role of matrix metalloproteinases in delayed cortical responses after stroke.. 12:441-5. 2006
- Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.. 12:856-61. 2006
- Regulation of lung injury and repair by Toll-like receptors and hyaluronan.. 11:1173-9. 2005
- Targeting toxic proteins for turnover.. 11:1052-3. 2005
- Diverse compounds mimic Alzheimer disease-causing mutations by augmenting Abeta42 production.. 11:545-50. 2005
- Inflammation takes on Alzheimer disease.. 8:936-8. 2002
- CREB family transcription factors inhibit neuronal suicide.. 8:450-1. 2002
- Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.. 7:1144-50. 2001
- Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease.. 5:1403-9. 1999
- Regenerating functional myocardium: improved performance after skeletal myoblast transplantation.. 4:929-33. 1998
- An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow.. 4:333-5. 1998
- Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia.. 3:1089-95. 1997
- Urinary bladder-urethral sphincter dysfunction in mice with targeted disruption of neuronal nitric oxide synthase models idiopathic voiding disorders in humans.. 3:571-4. 1997
- Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A.. 3:421-8. 1997